Global Companion Diagnostics Market - Latest Study Reveals New Growth Dynamics

Companion Diagnostics Market Latest Edition Published with Forecast to 2027
The article cited AMA's Global Companion Diagnostics Market Study explored substantial growth with CAGR of 14.6%. According to the study, Rise in Focus on Development of Personalized Medicine is one of the primary growth factors for the market. Increasing Demand for Targeted Therapy Amid Increasing Prevalence of Chronic Disease is also expected to contribute significantly to the Companion Diagnostics market. Overall, applications of Companion Diagnostics, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The presence of players such as F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies Inc. (United States), Qiagen N.V. (Germany), Thermo Fisher Scientific Inc. (United States), Abbott Laboratories Inc. (United States), Biomérieux SA (France), Danaher Corporation (United States), Illumina Inc. (United States), Myriad Genetics (United States), Arup Laboratories Inc. (United States), Sysmex Corporation (Japan), Hologic Inc. (United States) and Novartis AG (Switzerland) pushing strong cash flow in Market which is also a key in driving revenue growth.

AMA’s Analyst on the Global Companion Diagnostics market identified that the demand is rising in many different parts of the world as "Rise in Demand of Next-Generation Sequencing (NGS) ". One of the challenges that industry facing is "Lack of Availability of Skilled Personnel"

The report provides an in-depth analysis and forecast about the industry covering the following key features:

• Detailed Overview of Companion Diagnostics market will help deliver clients and businesses making strategies.
• Influencing factors that thriving demand and latest trend running in the market
• What is the market concentration? Is it fragmented or highly concentrated?
• What trends, challenges and barriers will impact the development and sizing of Companion Diagnostics market
• SWOT Analysis of profiled players and Porter's five forces & PEST Analysis for deep insights.
• What growth momentum or downgrade market may carry during the forecast period?
• Which region may tap highest market share in coming era?
• What focused approach and constraints are holding the Companion Diagnostics market tight?
• Which application/end-user category or Product Type [] may seek incremental growth prospects?
• What would be the market share of key countries like Germany, USA, France, China etc.?

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Companion Diagnostics market and other related sub-markets covered in the study.

o Key & emerging players in the Companion Diagnostics market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Companion Diagnostics market size is calculated using market estimation process, the Companion Diagnostics market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Companion Diagnostics market size has been validated using both top-down and bottom-up approaches.

Craig Francis

PR & Marketing Manager